基本信息
浏览量:32
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Marco Radi is Associate Professor of Medicinal Chemistry at the Department of Pharmacy of the University of Parma. He studied at the University of Siena (MSc cum Laude in Medicinal Chemistry, 2000; PhD in Medicinal Chemistry, 2004), doing his doctoral studies in solid-phase synthesis and antiviral drug-discovery with Maurizio Botta. He then did postdoctoral research at the University of Georgia (with David C.K. Chu; 2005-2006) where he pioneered the application of sub-zero microwave assisted technology for the synthesis of antiviral and anticancer nucleosides. He returned to the University of Siena as postdoctoral researcher (2006-2010) and then as untenured Assistant Professor (2010-2011). In December 2011 he moved to the University of Parma as permanent Assistant Professor at the School of Pharmacy, where he became Associate Professor in 2014.
Prof. Radi participated in different National (Programma per la Ricerca Regionale in Materia di Salute 2009; PRIN- 2007; PRIN-2008, PRIN-2010_2011, FIL-2012_2014) and International (CHAARM; ExCellENT-Hit; TRIoH; COST Angiokem, COST Glisten, Chiesi Foundation) multidisciplinary research projects. As PI or co-Investigator on these funded grants, he successfully administered the projects (e.g. recruitment, research planning, budget reports), collaborating with other international researchers and obtaining a few innovative results that led to several papers/patents: i) three different families of anti-HIV agents for drug-resistant forms (within TRIoH and CHAARM); ii) the first small molecule inhibitors of the human helicase DDX3 as broad-spectrum antivirals (within ExCellENT-Hit, PRIN-2008) Programma per la Ricerca Regionale in Materia di Salute 2009); iii) novel competitive and allosteric kinase inhibitors active on many different solid tumors (within COST Angiokem and PRIN-2007); iv) first-in-class Dengue Virus inhibitors (within FIL-2012_2014) and iv) broad spectrum antiviral agents (with the Chiesi Foundation grant).
He was also actively involved in the exploitation of the obtained research results by participating to the exclusive agreement between the University of Siena and Virostatics Srl for the licencing of the antitumor/antiviral compounds object of the patent application WO2009034547. He was involved in the exclusive agreement between the University of Siena and Centre National de la Recherche Scientifique (CNRS) for the licencing of the patent application WO2011073959. He was a co- author of the Business Plan “TKI Pharmaceutical”(based on the patent application WO2009034547) presented on 2006 at the scientific park Toscana Life Science. He was a co-author of the Business Plan “Lead Discovery Siena (LDS)” (based also on the patent application WO2009034547), winner of the 2009 edition of the Start Cup Toscana. He was a co-author and Proponent of the Business Plan “CoREX Pharm” (based on the patent application EP2388250) presented on 2012 at the scientific park Sardegna Ricerche. He was a co-author and Proponent of the Business Plan “AID-Discovery” (based on the patent application US 2012/0202814) presented on 2013 at the scientific park Sardegna Ricerche.
Prof. Radi is currently member of the Editorial Board of the Journal of Chemistry (since 2012), MC member of the COST Action CM1207 "GLISTEN” (since 2013) and Erasmus Delegate for the Department of Pharmacy (since 2012). He is member of the Department of Pharmacy and of the teacher board for the PhD programme "Drugs, Biomolecules and Health Products" at the University of Parma, where he supervise several undergraduates and PhD students in the field of medicinal chemistry. His present teaching activities are: i) Laboratory of drug analysis; ii) Database search for project planning. He is a peer reviewer for National (PRIN, FIRB, SIR) and International (IOFM, Horizon2020) research programs and referee for several medicinal chemistry and organic chemistry journals. Prof. Radi’s research activities are currently focused at the development of broad-spectrum antivirals (enterovirus family, Flavivirus family, HIV), anticancer agents, GPCRs modulators and kinase inhibitors, with a special focus on the rational design of multi-target drugs . His research interests are in the field of antiviral and anticancer drug discovery, with particular attention at the development of novel combinatorial methodologies to quickly produce highly functionalized chemical probes. He has authored more than 80 papers, book chapters and patent applications in these fields.
研究兴趣
论文共 135 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Francesca Barbieri, Vincent Carlen,Maria Grazia Martina,Filomena Sannio, Sacha Cancade,Cecilia Perini, Margherita Restori,Emmanuele Crespan,Giovanni Maga,Jean-Denis Docquier,Valeria Cagno,Marco Radi
RSC MEDICINAL CHEMISTRYno. 5 (2024): 1589-1600
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024): 116063-116063
European Journal of Organic Chemistrypp.e202400087, (2024)
European Journal of Organic Chemistry (2024)
Francesca Barbieri,Maria Grazia Martina,Carmine Giorgio, Maria Linda Chiara,Marika Allodi, Joseph Durante,Simona Bertoni,Marco Radi
ChemMedChempp.e202400389-e202400389, (2024)
Camilla Russo,Matthew C. Leech,Jamie M. Walsh,Joe I. Higham,Lisa Giannessi, Emmanuelle Lambert,Cyrille Kiaku,Darren L. Poole,Joseph Mason, Charles A. I. Goodall,Perry Devo,Mariateresa Giustiniano,
ANGEWANDTE CHEMIE-INTERNATIONAL EDITIONno. 38 (2023)
European Atherosclerosis Journalno. 1 (2023): 26-26
EUROPEAN JOURNAL OF ORGANIC CHEMISTRYno. 2 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn